我国结核病定点医疗机构实验室检测能力调查分析
|
|
王彪, 刘宇红, 孙玙贤, 张立杰, 李志丽, 舒薇
|
Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China
|
|
Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei
|
|
表2 各项检测技术在不同等级调查机构的开展情况
|
| |
|
| 检测技术 | 三级甲等 | 其他等级 | 合计 | χ2值 | P值 | 单位数 (家) | 构成比 (%) | 单位数 (家) | 构成比 (%) | 单位数 (家) | 构成比 (%) | | PCR检测 | | | | | | | 8.712 | 0.003 | | 未开展 | 7 | 29.2 | 16 | 72.7 | 23 | 50.0 | | | | 开展 | 17 | 70.8 | 6 | 27.3 | 23 | 50.0 | | | | 线性探针检测 | | | | | | | 0.011 | 0.918 | | 未开展 | 22 | 91.7 | 19 | 86.4 | 41 | 89.1 | | | | 开展 | 2 | 8.3 | 3 | 13.6 | 5 | 10.9 | | | | GeneXpert MTB/RIF检测 | | | | | | | 0.006 | 0.938 | | 未开展 | 1 | 4.2 | 2 | 9.1 | 3 | 6.5 | | | | 开展 | 23 | 95.8 | 20 | 90.9 | 43 | 93.5 | | | | 基因芯片检测 | | | | | | | 5.518 | 0.019 | | 未开展 | 15 | 62.5 | 21 | 95.5 | 36 | 78.3 | | | | 开展 | 9 | 37.5 | 1 | 4.5 | 10 | 21.7 | | | | 抗体检测 | | | | | | | 0.485 | 0.486 | | 未开展 | 5 | 20.8 | 2 | 9.1 | 7 | 15.2 | | | | 开展 | 19 | 79.2 | 20 | 90.9 | 39 | 84.8 | | | | IGRA检测 | | | | | | | 0.105 | 0.746 | | 未开展 | 4 | 16.7 | 2 | 9.1 | 6 | 13.0 | | | | 开展 | 20 | 83.3 | 20 | 90.9 | 40 | 87.0 | | | | LAMP检测 | | | | | | | 0.637 | 0.425 | | 未开展 | 16 | 66.7 | 17 | 77.3 | 33 | 71.7 | | | | 开展 | 8 | 33.3 | 5 | 22.7 | 13 | 28.3 | | | | HRM检测 | | | | | | | 0.080 | 0.777 | | 未开展 | 11 | 45.8 | 11 | 50.0 | 22 | 47.8 | | | | 开展 | 13 | 54.2 | 11 | 50.0 | 24 | 52.2 | | | | 分子菌种鉴定(基因芯片或测序) | | | | | | | 6.002 | 0.014 | | 未开展 | 10 | 41.7 | 17 | 77.3 | 27 | 58.7 | | | | 开展 | 14 | 58.3 | 5 | 22.7 | 19 | 41.3 | | |
|
|
|